Start an analysis for HHS
Harte-Hanks, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $7m | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Remaining authorization | $4m | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 02-May-23 | $7m | $4m | n/a | On May 2, 2023, the Board of Directors of the Company approved a share repurchase program to maximize shareholder value with authorization to repurchase $6.5 million of the Company’s Common Stock.10-Q filed 13-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 13-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 13-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 13-Nov-26 |